NewEdge Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Buy
9,391
+55
+0.6% +$9.4K 0.02% 493
2025
Q4
$1.58M Sell
9,336
-27
-0.3% -$4.38K 0.02% 515
2025
Q3
$1.48M Buy
9,363
+1,928
+26% +$263K 0.02% 466
2025
Q2
$976K Sell
7,435
-407
-5% -$50K 0.02% 539
2025
Q1
$1M Buy
7,842
+312
+4% +$42.3K 0.02% 483
2024
Q4
$996K Sell
7,530
-1,110
-13% -$156K 0.02% 488
2024
Q3
$1.26M Buy
8,640
+1,965
+29% +$284K 0.02% 432
2024
Q2
$916K Sell
6,675
-1,587
-19% -$212K 0.02% 431
2024
Q1
$1.08M Sell
8,262
-232
-3% -$31.7K 0.02% 416
2023
Q4
$1.15M Buy
8,494
+5,129
+152% +$626K 0.03% 377
2023
Q3
$411K Sell
3,365
-315
-9% -$40.1K 0.01% 483
2023
Q2
$467K Sell
3,680
-441
-11% -$57.3K 0.02% 465
2023
Q1
$532K Buy
4,121
+34
+0.8% +$4.45K 0.02% 402
2022
Q4
$537K Buy
4,087
+1,245
+44% +$161K 0.02% 358
2022
Q3
$332K Buy
2,842
+200
+8% +$24.8K 0.02% 409
2022
Q2
$311K Sell
2,642
-7,803
-75% -$926K 0.01% 458
2022
Q1
$1.36M Buy
10,445
+7,858
+304% +$1.02M 0.06% 193
2021
Q4
$395K Buy
+2,587
New +$401K 0.02% 316

Other funds holding IBB

NewEdge Wealth's IBB Position: Q1 2026 in Review

NewEdge Wealth increased its iShares Biotechnology ETF (IBB) stake by 0.59% in Q1 2026, buying an estimated $9.4K and bringing the position to 9,391 shares worth $1.59M. The position accounts for 0.02% of the portfolio, ranked #493.

NewEdge Wealth first reported a position in IBB in Q4 2021 and has held it in 18 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • NewEdge Wealth held 9,391 shares of iShares Biotechnology ETF worth $1.59M as of Q1 2026.
  • NewEdge Wealth bought 55 iShares Biotechnology ETF shares in Q1 2026, an estimated $9.4K.
  • iShares Biotechnology ETF made up 0.02% of NewEdge Wealth's portfolio in Q1 2026, its #493 holding.
  • NewEdge Wealth first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 18 quarters since.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.